Summary: Honasa Consumer Limited, the company behind brands like Mamaearth, has officially announced its entry into the health and wellness supplement space by acquiring a 58 percent controlling stake in Fluence Pharma.
With a large digital sales platform and medical grade skin and hair nutrition, the company is looking to tap into the growing wellness space in India. The company announced plans to grow from topical creams and shampoos to tackling beauty from the inside out.
Honasa Consumer Limited is currently trading at Rs 405 after yesterday’s closing price of Rs 419.9 . The stock opened at Rs429.05 and striked a day high of Rs 430.4; the day’s low so far is Rs 403.5. The current market capitalisation of the company is Rs 13,209 crore, with a price-to-earnings ratio of 64.8 times, which is higher than the peer median industry ratio of 40.12 times.
Deal
Honasa has purchased a 58% controlling stake in Fluence Pharma, a highly specialized company known for its unique, sequenced nutrition routines designed for complex skin and hair conditions. Fluence Pharma comes into this partnership with an impressive financial track record, reporting around ₹40 crores in revenue and healthy profit margins exceeding 20% for the 2026 fiscal year.
Operational Strategy
Honasa Consumer Limited will form Honasa Health Private Limited to expand its category presence after this acquisition. This new entity will scale a differentiated B2C nutrition portfolio using Fluence’s patented clinical science, deep practitioner trust, brand building, consumer insights, and digital first distribution expertise.
Honasa will use its internet marketing skills, customer data, and nationwide distribution network of online stores and nearly three lakh retail shops to scale Fluence’s medically proven formulas into mainstream consumer products.
Recent Quarter Results
Coming into financial highlights, Honasa Consumer Limited’s revenue has increased year on year from Rs 534 crore in Q4 FY25 to Rs 657 crore in Q4 FY26 reflecting a healthy growth of 23.03 percent, and increased from Rs 602 crore, indicating a slight increase of 9.13 percent from Q3 FY26 to Q4 FY26.
The net profit jumped from Rs 25 crore in Q4 FY25 to Rs 69 crore in Q4 FY26. Honasa Consumer Limited’s revenue has grown at a CAGR of 39 percent over the last 5 years, while its profit has grown at a CAGR of 17 percent.
In terms of return ratios, the company’s ROCE and ROE stand at 19.2 percent and 15.7 percent, respectively. Honasa Consumer Limited has an earnings per share (EPS) of Rs 2.13 as of Q4 FY26, and its debt-to-equity ratio is 0.10 times.
Bottom line
This acquisition reduces the company’s reliance on standard cosmetics by opening up a brand-new revenue stream in a premium, high-margin category. By purchasing an already profitable business with strong scientific roots rather than building a supplement brand from scratch, Honasa has created a safer, faster path to future growth while building out its collection of modern consumer brands.
Honasa Consumer Limited is a leading beauty & personal care brands in India with brands like Mamaearth, The Derma Co. and Aqualogica. It has a strong network online and offline and retails skin care, hair care and wellness products across India. It has not only a strong offline presence across 3 lakh plus retail outlets but also a strong omni-channel distribution network, covering more than 95 percent of India’s pin codes through its D2C and e-commerce platforms.
